Latest Industry Insights
Industry Insight
Driving Innovation While Navigating Global Pressures: How One Life Science Company Is Evolving With the Market
As global scientific and regulatory landscapes shift, companies across the life sciences sector are under growing pressure to adapt. Hear how Phenomenex are taking a proactive approach.
Industry Insight
Whole-Genome Sequencing Enables Rare Variant Discovery at Scale
Illumina’s Rami Mehio discusses the whole-genome sequencing of 490,640 UK Biobank participants with Molly Coddington for Technology Networks.
Industry Insight
Breaking Diagnostic Barriers in Alzheimer’s With Fluid Biomarkers
Technology Networks recently spoke with Cristiano Tunesi to learn more about how cerebrospinal fluid biomarkers are transforming Alzheimer’s diagnosis, offering earlier and more accurate detection to guide treatment and improve outcomes.
Industry Insight
The Allergy–Mental Health Interface: Implications for Early Diagnosis and Personalized Care
In this interview, we explore the relationship between allergies and mental health, and how advances in diagnostic testing could help clinicians offer more personalized patient care.
Industry Insight
Academic Origins Driving Impact in Epigenetic Diagnostics
An epigenetic analysis platform spun out of academia could address current issues with wider adoption of epigenetic profiling as a cancer diagnostic tool. Hear about the challenges, successes and importance of industry partners.
Industry Insight
ctDNA, CTCs and the Future of Liquid Biopsy
Discover insights on the challenges of CTCs and ctDNA from liquid biopsies as cancer diagnostic tools, how novel technology is helping to overcome some of these issues and the future monitoring landscape.
Industry Insight
A New Era Begins for Diagnostic Testing
The diagnostics landscape has transformed over the last 12 months. In this interview, Mara Aspinall, a leader in diagnostic innovation, policy and partner at Illumina Ventures, reflected on the defining moments of the last year and what lies ahead.
Industry Insight
Beyond the Scale: How Targeted Weight Loss Transforms Metabolic Health and Lowers Healthcare Costs
Weight loss isn’t just cosmetic; it prevents chronic disease, saves money and improves mental and physical well-being. Explore the latest weight loss research and learn how even moderate weight loss can transform metabolic health.
Industry Insight
Transforming Healthcare With Person-Centered Digital Approaches
Following the Galien Forum, Technology Networks spoke with Sanket Shah, president of Otsuka Precision Health, to learn how the company is advocating for healthcare change by combining digital innovation with meaningful human connection.
Industry Insight
Precision Medicine at Novo Nordisk Uses AI To Combat Obesity
Novo Nordisk’s Transformational Prevention Unit (TPU) integrates AI, omics, and genomics to predict obesity risk and tailor interventions. By focusing on personalized solutions, TPU aims to prevent obesity and reduce the incidence of related diseases
Advertisement
